HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
OMER
Omeros Corporation
Healthcare Biotechnology · Washington, USA · Reports in usd
Market Cap: $889.1M
Market Cap
$889.1M
Enterprise Val
$1.12B
P/E Ratio
-265.40
P/B Ratio
-7.33
Trailing PEG (1Y)
0.74
As Of
Apr 15, 2026

Overview & Key Metrics

Reporting period: Dec 31, 2025 · Q4 2025
Book Value-$121.2M
Return on Equity1.71%
Return on Assets-1.41%
Current Ratio2.76
Debt/Equity-3.36
LT Debt/Equity-3.00
Revenue Per Share0.00

Income Statement

Dec 31, 2025
Revenue$0.00
Cost of Revenue$0.00
Gross Profit$0.00
R&D$19.4M
SG&A$9.6M
Operating Expenses$29.1M
Operating Income-$29.1M
Interest Expense$8.7M
Tax Expense$2.0M
Net Income$86.5M
EPS (Basic)$1.42
EPS (Diluted)$1.42
EBIT$97.2M
EBITDA$97.4M
Consolidated Income$86.5M
Non-Controlling Interests$0.00

Balance Sheet

Dec 31, 2025
Cash & Equivalents$9.7M
Accounts Receivable$10.9M
Inventory$0.00
Current Assets$215.7M
LT Investments$1.1M
Property, Plant & Equipment$12.5M
Intangibles$0.00
Non-Current Assets$110.0M
Total Assets$325.6M
Accounts Payable$4.8M
Current Debt$43.9M
Current Liabilities$78.1M
LT Debt$363.1M
Non-Current Liabilities$368.8M
Total Liabilities$446.9M
Total Debt$407.0M
Retained Earnings-$913.7M
Shareholder Equity-$121.2M
Shares Outstanding70,900,459

Cash Flow Statement

Dec 31, 2025
Operating Cash Flow-$39.8M
Investing Cash Flow$111.5M
Financing Cash Flow-$64.4M
CapEx$0.00
Free Cash Flow-$39.8M
Depreciation & Amort.$235.0K
Stock-Based Comp$1.7M
Acquisitions / Disposals$240.0M
Investment Activity-$128.5M
Debt Issued/Repaid-$75.5M
Equity Issued/Repaid$11.1M
Dividends Paid$0.00
Net Change in Cash$7.3M
Data cached · Meta live · Daily live · Statements live · TTL 24h